Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Techniclone (TCLN) -- Ignore unavailable to you. Want to Upgrade?

To: Terry D. who wrote (2439)	8/16/1998 9:22:00 PM
From: shero	Read Replies (2) \| Respond to of 3702

Terry, I think there was one study funded by PAACT/NIH, I'm not sure, with 7 patients who had advanced prostate cancer. Early 90's, I think. Data was probably published, I may have something in my files. I'll check. The TNT data from China was not translated into English. Epstein provided a friend with a 2 page summary. However it is available in Mandarin. A researcher in Phil Thorpes' laboratory is fluent in that language and reviewed the data for Peregrine prior to the acquisition by TCLN. That Peregrine agreed to the acquisition, to me speaks volumes. Of course to someone who needs a reason to buy the stock based on facts, my conjecture is only...my conjecture. Maurice, you are, of course, right. By the time all the facts are public the stock will be higher. And there will be plenty of money to be made, if this stuff works, for those who want the facts before they invest. But for someone with your attitude your not buying the stock here baffles me. It seems you are talking out of both sides of your mouth. Just my opinion.